Kazazian Asset Management, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Kazazian Asset Management, LLC
- $131 Billion
- Q4 2024
A detailed history of Kazazian Asset Management, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Kazazian Asset Management, LLC holds 950 shares of MDGL stock, worth $320,682. This represents 0.22% of its overall portfolio holdings.
Number of Shares
950Holding current value
$320,682% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
305Shares Held
22.3MCall Options Held
743KPut Options Held
646K-
Janus Henderson Group PLC London, X02.48MShares$837 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$689 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$685 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$673 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$667 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.77B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...